Recombinant multi-species NTS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NTS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a common precursor for two peptides, neuromedin N and neurotensin. Neurotensin is a secreted tridecapeptide, which is widely distributed throughout the central nervous system, and may function as a neurotransmitter or a neuromodulator. It may be involved in dopamine-associated pathophysiological events, in the maintenance of gut structure and function, and in the regulation of fat metabolism. Neurotensin also exhibits antimicrobial activity against bacteria and fungi. Tissue-specific processing may lead to the formation in some tissues of larger forms of neuromedin N and neurotensin. The large forms may represent more stable peptides that are also biologically active. [provided by RefSeq, Oct 2014]
The Alternative Names of target: NTS,Neurotensin/neuromedin N,NN,NT,NT/N,NTS1,NMN-125

Target products collectionGo to NTS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1140-Ab-1/ GM-Tg-hg-SE1140-Ab-2 Human NTS protein Human
GM-Tg-rg-SE1140-Ab-1/ GM-Tg-rg-SE1140-Ab-2 Rat NTS protein Rat
GM-Tg-mg-SE1140-Ab-1/ GM-Tg-mg-SE1140-Ab-2 Mouse NTS protein Mouse
GM-Tg-cynog-SE1140-Ab-1/ GM-Tg-cynog-SE1140-Ab-2 Cynomolgus/Rhesus macaque NTS monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1140-Ab-1/ GM-Tg-felg-SE1140-Ab-2 Feline NTS protein Feline
GM-Tg-cang-SE1140-Ab-1/ GM-Tg-cang-SE1140-Ab-2 Canine NTS protein Canine
GM-Tg-bovg-SE1140-Ab-1/ GM-Tg-bovg-SE1140-Ab-2 Bovine NTS protein Bovine
GM-Tg-equg-SE1140-Ab-1/ GM-Tg-equg-SE1140-Ab-2 Equine NTS protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1140-Ab-1/ GM-Tg-hg-SE1140-Ab-2; GM-Tg-rg-SE1140-Ab-1/ GM-Tg-rg-SE1140-Ab-2;
GM-Tg-mg-SE1140-Ab-1/ GM-Tg-mg-SE1140-Ab-2; GM-Tg-cynog-SE1140-Ab-1/ GM-Tg-cynog-SE1140-Ab-2;
GM-Tg-felg-SE1140-Ab-1/ GM-Tg-felg-SE1140-Ab-2; GM-Tg-cang-SE1140-Ab-1/ GM-Tg-cang-SE1140-Ab-2;
GM-Tg-bovg-SE1140-Ab-1/ GM-Tg-bovg-SE1140-Ab-2; GM-Tg-equg-SE1140-Ab-1/ GM-Tg-equg-SE1140-Ab-2
Products Name NTS protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NTS
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NTS protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.